4478 related articles for article (PubMed ID: 608525)
1. Effects of BCG and C. parvum treatment on human melanoma xenografts.
Garrett AJ; Reeson DE; Osborn TW; Boulger LR
Dev Biol Stand; 1977 Apr 13-15; 38():363-8. PubMed ID: 608525
[TBL] [Abstract][Full Text] [Related]
2. Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients.
Thatcher N; Crowther D
Dev Biol Stand; 1977 Apr 13-15; 38():449-53. PubMed ID: 608536
[TBL] [Abstract][Full Text] [Related]
3. [BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16].
Gankovskaia LV; Pyl'nova TI; Sokolova EV; Koval'chuk LV
Biull Eksp Biol Med; 1980 Sep; 90(9):346-8. PubMed ID: 7000202
[TBL] [Abstract][Full Text] [Related]
4. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
Scott MT; Milas L
Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
[TBL] [Abstract][Full Text] [Related]
5. Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions.
Thatcher N; Swindell R; Crowther D
Clin Exp Immunol; 1979 Feb; 35(2):171-9. PubMed ID: 312169
[TBL] [Abstract][Full Text] [Related]
6. Effect of glucan and other adjuvants on the clearance of radiolabeled tumor cells from mouse lungs.
Proctor JW; Stiteler RD; Yamamura Y; Mansell PW; Winters R
Cancer Treat Rep; 1978 Nov; 62(11):1873-80. PubMed ID: 728905
[TBL] [Abstract][Full Text] [Related]
7. Host responses in adjuvant contact suppression of experimental rat tumours.
Pimm MV; Hopper DG; Baldwin RW
Dev Biol Stand; 1977 Apr 13-15; 38():349-54. PubMed ID: 344098
[TBL] [Abstract][Full Text] [Related]
8. Results of adjuvant BCG immunotherapy in malignant melanoma.
Wätzig V; Knopf B
Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442
[TBL] [Abstract][Full Text] [Related]
9. [Effect of intra-tumoral injection of tuberculin-active protein on growth of transplantable mouse melanomas].
Saida T
Nihon Hifuka Gakkai Zasshi; 1982 Nov; 92(13):1389-98. PubMed ID: 6984864
[No Abstract] [Full Text] [Related]
10. A bladder tumor model response to immunotherapy.
deKernion JB; Ramming KP; Fraser K
Natl Cancer Inst Monogr; 1978 Dec; (49):333. PubMed ID: 748789
[TBL] [Abstract][Full Text] [Related]
11. Corynebacterium parvum versus bacille Calmette-Guérin adjuvant immunotherapy of stage II malignant melanoma.
Lipton A; Harvey HA; Balch CM; Antle CE; Heckard R; Bartolucci AA
J Clin Oncol; 1991 Jul; 9(7):1151-6. PubMed ID: 2045856
[TBL] [Abstract][Full Text] [Related]
12. A new mouse model of experimental melanoma for vaccine and lymphokine therapy.
Shrayer DP; Bogaars H; Wolf SF; Hearing VJ; Wanebo HJ
Int J Oncol; 1998 Aug; 13(2):361-74. PubMed ID: 9664134
[TBL] [Abstract][Full Text] [Related]
13. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
[TBL] [Abstract][Full Text] [Related]
14. Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice.
Sabzevari H; Reisfeld RA
Cancer Res; 1993 Oct; 53(20):4933-7. PubMed ID: 8402683
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant immunotherapy.
Goodnight JE; Morton DL
Int Adv Surg Oncol; 1978; 1():53-83. PubMed ID: 399764
[TBL] [Abstract][Full Text] [Related]
16. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
[TBL] [Abstract][Full Text] [Related]
17. Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions.
Thatcher N; Swindell R; Crowther D
Clin Exp Immunol; 1979 May; 36(2):227-36. PubMed ID: 314367
[TBL] [Abstract][Full Text] [Related]
18. [Cancer immunotherapy in dermatological view (author's transl)].
Lübbe D; Gstöttner R
Arch Geschwulstforsch; 1980; 50(2):182-5. PubMed ID: 7436703
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of malignant melanoma.
Rosenberg SA
Cancer Treat Rep; 1976 Feb; 60(2):159-63. PubMed ID: 769968
[TBL] [Abstract][Full Text] [Related]
20. Effect of Corynebacterium parvum on subcutaneous and skeletal methylcholanthrene sarcoma implants.
Boak JL; Tebbutt S
Clin Oncol; 1977 Dec; 3(4):353-63. PubMed ID: 598063
[No Abstract] [Full Text] [Related]
[Next] [New Search]
